Sonire Therapeutics

Developer of high intensity focused ultrasound treatment systems

placeTokyo, Tokyo, Japan calendar_todayFounded 2020 groups17 employees language sonire-therapeutics.com

Social engagement

Social engagement: 712 social following, 6 posts in the last 12 months — below the industry typical range.

Investor mix

17 investors on record; lead investors include Fast Track Initiative, Sante.

Investor typeCountShare
Venture capital1059%
Private equity212%
Other / undisclosed529%

Recent activity

1 Jun 2026
Milestone
regulatory
1 May 2026
Milestone
regulatory
Coming soon